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Concise report
Metatarsophalangeal joint pain in psoriatic arthritis:
a cross-sectional study
Deborah E. Turner1, Elaine Hyslop1,2, Ruth Barn1, Iain B. McInnes3,
Martijn P. M. Steultjens1 and James Woodburn1
Abstract
Objective. The aim of this study was to identify independent predictors of pain at the MTP joints in
patients with PsA.
Methods. Thirty-four consecutive patients with PsA (mean age 45.3 years, 65% female, mean disease
duration 9.9 years) and 22 control participants (mean age 37.9 years, 64% female) underwent clinical and
US examination to determine the presence of pain, swelling, synovitis, erosions, effusions and submeta-
tarsal bursae at the MTP joints. Mean barefoot peak plantar pressures were determined at each MTP joint.
Levels of pain, US-determined pathology and peak pressures were compared between groups. Binary
logistic regression was used to identify demographic, clinical examination-derived, US-derived and plantar
pressure predictors of pain at the MTP joints in the PsA group.
Results. The presence of pain, deformity, synovitis, erosions (P< 0.001) and submetatarsal bursae and
peak plantar pressure at MTP 3 (P<0.05) were significantly higher in the PsA group. MTP joint pain in PsA
was independently predicted by high BMI, female gender and the presence of joint subluxation, synovitis
and erosion.
Conclusion. These results suggest local inflammatory and structural factors, together with systemic fac-
tors (gender, BMI), are predominantly responsible for painful MTP joints in PsA, with no clear role for
plantar pressure characteristics.
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Introduction
Forefoot structural damage and pain are common in
patients with PsA [13] and has been shown to be asso-
ciated with clinically important levels of impairment and
disability [4]. While the magnitude of foot impairments and
related disability in PsA is comparable to that reported in
RA, to date, relatively few studies have integrated bio-
mechanical and inflammatory measures to determine the
underlying dominant mechanisms operating in PsA.
US-detected active disease (synovial hypertrophy, effu-
sion) at the MTP joints is common in PsA and is detected
with twice the frequency of clinical examination tech-
niques, but is poorly correlated to pain [3]. There are
likely some parallels between some of the structural path-
ology seen at the MTP joints in PsA and those in RA,
namely synovial hypertrophy, joint subluxation and ero-
sive changes. PsA, however, has a distinct bone morph-
ology, not least of which is the propensity for new bone
formation arising alongside erosion. It is recognized that
the causes of pain at the MTP joint level are complex and
may not be wholly related to inflammation [3] and that
increased mechanical pressure over structurally damaged
metatarsal heads may be important [56]. Indeed, in RA,
MTP joint peak pressures are elevated and significant re-
lationships between high forefoot pressures, structural
damage, pain and foot-related disability have been
demonstrated [68]. Therefore we hypothesize that the
same mechanisms may be equally important in
PsA—but this has not been investigated. Thus the aim
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of this study was to identify independent predictors of
forefoot pain at the MTP joints in patients with PsA.
Method
Local ethical approval was obtained from the West of
Scotland Local Research Ethics Committee (reference
09/S0704/14) and NHS Greater Glasgow and Clyde
Research and Development Committee (reference
GN09RH181) for this study, which was conducted ac-
cording to requirements of the Declaration of Helsinki.
All study participants gave written informed consent.
Patients with a confirmed diagnosis of PsA, based on
the ClASsification criteria for Psoriatic Arthritis (CASPAR)
[9], were consecutively recruited from rheumatology out-
patient clinics at the Glasgow Royal Infirmary and control
participants from healthy (i.e. asymptomatic) university-
based staff. In one data collection session, the feet of all
participants were examined for MTP joint pain, tenderness
and swelling, joint subluxation (i.e. dislocation or instability
of the joint) and lesser toe bony deformity. Demographic
data were collected, including disease duration, gender,
age and BMI.
All participants underwent US examination using an
Esaote Mylab 70 scanner (Esaote, Genoa, Italy) with
multilinear 1618 MHz probe. The sonographer was
blinded to the clinical examination findings. All 10 MTP
joints were scanned according to the protocol described
by Szkudlarek et al. [10]. Grey scale synovitis, erosions
and effusions were defined according to the OMERACT
definition [11] and scored dichotomously. Submetatarsal
bursae were defined according to Hooper et al. [12].
Power Doppler (PD) signal was assessed with a pulse
repetition frequency of 750 Hz, low wall filter, gain ad-
justed until the background signal was removed and
minimal probe pressure. Barefoot mean peak plantar
pressures were determined for each metatarsal head
derived from five walking trials using an Emed X system
(Novel GmbH, Munich, Germany) [13].
MannWhitney U and chi-square tests were used to
compare the PsA and healthy control groups. To identify
predictors of MTP joint pain, a binary logistic regression
analysis was performed. The dependent variable was the
presence or absence of pain in the joint upon clinical
examination. Age, gender, other features found on clinical
examination (swelling, deformation, subluxation) or US
examination (synovitis, erosion, effusion, PD, bursae)
and plantar pressure were included in the initial model
as potential predictors. Through a process of backward
stepwise elimination, the model was reduced to include
only those predictors with a P-value below the removal
threshold value (P-out) of 0.10. This regression analysis
was performed at the individual joint level, i.e. K= 340
joints from N= 34 participants.
Results
Thirty-four PsA patients and 22 control participants were
recruited. A total of 340 and 220 MTP joints were exam-
ined in the PsA and control groups, respectively. The
demographics,clinical and US features and peak plantar
foot pressures are presented in Table 1. In the PsA group,
129 joints were found to be painful, compared with no
joints in the control group. Although subluxation and
deformity of the joints were found in the control group,
these were more prevalent in the PsA group. Effusion
was the most prevalent US feature in both groups (46%
PsA, 41% control). The prevalence of synovitis and ero-
sion were both 14% in the PsA group, while these were
absent in the control group. For these features, additional
TABLE 1 Demographics and clinical, US and biomechanical features
PsA (n=34) Control (n=22) Test result P-value
Age, mean (S.D.) (range), years 45.3 (13.0) (2171) 37.9 (10.4) (2260) t= 2.24, df = 54 0.03
Female, n (%) 22 (64.7) 14 (63.6) 2 = 0.01, df = 1 0.94
BMI, mean (S.D.) (range) 25.1 (3.7) (18.832.9) 24.4 (2.7) (20.228.8) t= 0.81, df = 54 0.42
Clinically painful MTP joints, n (%) 129 (32) 0 (0) 2 = 109.2, df = 1 <0.001
Clinically swollen MTP joints, n (%) 10 (3) 0 (0) Fisher’s exact test 0.08
Clinically subluxed MTP joints, n (%) 173 (51) 40 (18) 2 = 60.6, df = 1 <0.001
Clinically deformed MTP joints, n (%) 233 (69) 53 (24) 2 = 105.6, df = 1 <0.001
US synovitis MTP joints, n (%) 47 (14) 0 (0) 2 = 33.2, df = 1 <0.001
US erosion MTP joints, n (%) 46 (14) 0 (0) 2 = 32.4, df = 1 <0.001
US effusion MTP joints, n (%) 158 (46) 91 (41) 2 = 1.41, df = 1 0.24
US PD-positive MTP joints, n (%) 6 (2) 0 (0) Fisher’s exact test 0.086
US MTP joint bursa, n (%) 92 (27) 42 (19) 2 = 4.66, df = 1 0.03
PP MTP joint 1, median (IQR) 263.1 (186.3488) 318.3 (266.7397.5) U= 1253, z=1.265 0.206
PP MTP joint 2, median (IQR) 420.5 (313.3667.3) 364 (291467.5) U= 1139, z=1.955 0.051
PP MTP joint 3, median (IQR) 396.5 (317.5392) 330 (267392) U= 979.5, z=2.921 0.003
PP MTP joint 4, median (IQR) 255 (202299.5) 235 (198301.7) U= 1302, z=0.969 0.333
PP MTP joint 5, median (IQR) 228.5 (130.4315.8) 163 (118341.7) U= 1248, z=1.295 0.195
PP: plantar pressure; IQR: interquartile range; t: Student’s independent groups t-test result; df: degrees of freedom;
2: chi-square test for independence; U: MannWhitney U test result with Monte Carlo exact significance; z: z score.
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tests (results not shown) revealed that these group differ-
ences were consistent between joints, i.e. not linked to a
specific joint location. Peak plantar pressure was different
between groups for MTP 3 and showed a borderline sig-
nificant difference for MTP 2, with the PsA group showing
higher pressure.
The final binary logistic regression model identifying in-
dependent predictors of joint pain in the PsA group is
presented in Table 2. Summary statistics for this model
were 2 log likelihood = 394.373 and Nagelkerke
R2= 0.204. Age, swelling and deformity on clinical exam-
ination, US-derived effusion, PD and bursa and plantar
pressure were dropped from the model in the course of
the backward elimination process, leaving female gender,
higher BMI and the presence of subluxation, synovitis and
erosion as significant predictors of MTP joint pain.
Additional per-MTP analyses (data not shown) confirmed
this overall model. Plantar pressure significantly predicted
pain for MTP 4 only, while US-derived effusion signifi-
cantly predicted pain in MTP 5.
Discussion
This study has identified that MTP joints that are subluxed
and have US-proven synovitis or erosion in female PsA
patients with higher BMI are most likely to be painful.
No clear role for plantar pressure was found in explaining
PsA-related MTP joint pain.
Anatomical site-specific models of disease burden and
pain have been studied in other arthritic conditions. In RA,
plantar pressure has been shown to be elevated at the
MTP joints, and this has been associated with pain and
disability [68]. In this PsA study, these results could not
be replicated, with limited evidence for elevated plantar
pressure and for plantar pressure predicting which joints
are painful. Studies in OA have previously shown the value
of combining measures of inflammation and function
[1718]. In contrast to the findings reported here, US fea-
tures of synovitis did not correlate with MTP pain, but
reduced joint function correlated with joint space narrow-
ing and osteophytosis in OA [17]. Moreover, in hand OA,
synovial pathology has been shown to be variably asso-
ciated with some measures of pain and impaired function
[18]. Comparing these findings with the present results,
which are dominated by inflammatory factors, indicates
that models of joint pain may be disease and joint specific.
A different balance between inflammatory and mechanical
factors may exist even in superficially similar arthritic
disorders.
There are several potential limitations to this study.
First, the sample size is relatively small. Second, no
causal inferences can be made in this cross-sectional
data set. Finally, the assessment of joint pain was done
in a qualitative (absent/present) manner during clinical
examination and did not take into account pain severity
or frequency, nor the subjective nature of pain reporting.
In summary, this work supports an explanatory model
of peripheral joint pain in PsA that includes local inflam-
matory and structural factors as well as systemic charac-
teristics (gender, BMI).
Rheumatology key messages
. MTP joint pain and other foot impairments are
common in PsA.
. Synovitis, erosion and subluxation of the MTPs
predict MTP pain in PsA.
. Plantar pressure is not linked to MTP pain in PsA.
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